Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERCC1 | P07992 | 1/20 | 0.63 |
| ▸ | FEN1 | P39748 | 1/20 | 0.63 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | MEN1 | O00255 | 4/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.62 |
| ▸ | HEXA | P06865 | 5/20 | 0.58 |
| ▸ | HEXB | P07686 | 5/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.56 |
| ▸ | OGA | O60502 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19450565 | 0.86 | ERCC1 (0.53) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL1101925 | 0.85 | KMT2A (0.62) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL12672646 | 0.85 | ALDH1A1 (0.51) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL13206583 | 0.82 | MPO (0.73) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL8927321 | 0.82 | BRD1 (0.59) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL30072176 | 0.82 | CYP1B1 (0.70) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL13009257 | 0.81 | KMT2A (0.56) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL15243610 | 0.81 | ALDH1A1 (0.55) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL4857545 | 0.81 | KMT2A (0.56) | ERCC1FEN1ERCC4ALDH1A1MEN1 | |
| SCHEMBL14463508 | 0.80 | KDM4E (0.59) | ERCC1FEN1ERCC4ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 761 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109535767-B | Preparation method of perylene pigment | 江苏丽王科技股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-109535767-A | The preparation method of one germline pigment | 江苏丽王科技股份有限公司 | 2019-03-29 | — | — | CN | claimed |
| US-20090215815-A1 | Neurotrophin antagonist compositions | PAINCEPTOR PHARMA CORPORATION (CA) | 2009-08-27 | — | — | US | claimed |
| EP-0930883-B1 | NEUROTROPHIN ANTAGONISTS FOR THE TREATMENT OF EPILEPSY, ALZHEIMER'S DISEASE AND PAIN | ALLELIX BIOPHARMA (CA) | 2006-01-11 | — | — | EP | claimed |
| US-20050250807-A1 | Neurotrophin antagonist compositions | TEHIM ASHOK | 2005-11-10 | — | — | US | claimed |
| EP-1010731-B1 | Process for the preparation of highly chromatic perylene pigments | SUN CHEMICAL CORP (US) | 2004-11-03 | — | — | EP | claimed |
| US-20020169182-A1 | Neurotrophin antagonist compositions | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 2002-11-14 | — | — | US | claimed |
| CN-1093645-C | Photoresist material and method for producing semiconductor constituted of corrosion resist picture thereof | NEC CORP (JP) | 2002-10-30 | — | — | CN | claimed |
| EP-1217043-A2 | Process for the preparation of perylene pigments | Bayer Corporation (US) | 2002-06-26 | — | — | EP | claimed |
| US-6403797-B1 | REACTING MIXTURE COMPRISING PERYLENE TETRACARBOXYLIC COMPOUND, AMPHOTERIC SURFACTANT, AND EXCESS AMMONIA OR PRIMARY AMINE TO FORM INTERMEDIATE, HEATING IN PRESENCE OF NON-PIGMENTARY CYCLIC ANHYDRIDE OR IMIDE, COLLECTING PIGMENT | BAYER CORPORATION | 2002-06-11 | — | — | US | claimed |
| EP-1010731-A2 | Process for the preparation of highly chromatic perylene pigments | Bayer Corporation (US) | 2000-06-21 | — | — | EP | claimed |
| US-6015458-A | Process for the preparation of highly chromatic perylene pigments | BAYER CORPORATION (US) | 2000-01-18 | — | — | US | claimed |
| CN-1227355-A | Photoresist material and method for producing semiconductor constituted of corrosion resist picture thereof | NEC CORP (JP) | 1999-09-01 | — | — | CN | claimed |
| EP-0930883-A1 | NEUROTROPHIN ANTAGONIST COMPOSITIONS | Allelix Biopharmaceuticals Inc. (CA) | 1999-07-28 | — | — | EP | claimed |
| WO-1998017278-A1 | NEUROTROPHIN ANTAGONIST COMPOSITIONS | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1998-04-30 | — | — | WO | claimed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| EP-0019749-A1 | Process for optical bleaching and dyeing synthetic fibres | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215815-A1 | Neurotrophin antagonist compositions | NGF, NTRK2, BDNF | ERCC1 4624/4885FEN1 4048/4885ERCC4 4849/4885 |
| US-20050250807-A1 | Neurotrophin antagonist compositions | NGF, NTRK2, BDNF | ERCC1 4702/4885FEN1 4282/4885ERCC4 4858/4885 |
| US-20020169182-A1 | Neurotrophin antagonist compositions | NTRK2, NGF, BDNF | ERCC1 4459/4885FEN1 4358/4885ERCC4 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.